ANDREW C CANNONS
Medical Practice at Clf Lk Ln, Tampa, FL
License number
Florida 42322
Issued Date
Apr 22, 2009
Effective Date
Oct 4, 2002
Expiration Date
Aug 31, 2018
Category
Health Care
Type
Clinical Laboratory Personnel
Address
Address
9024 Cliff Lake Ln, Tampa, FL 33614
Phone
(813) 888-7143
Professional information
Laboratory Director, Fl Department Of Health Tampa
Position:
Scientific Director at USF Center for Biological Defense
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Higher Education
Work:
USF Center for Biological Defense
- Tampa/St. Petersburg, Florida Area since Jul 2002
-
Scientific Director
USF Center for Biological Defense
Jul 2002 - Mar 2012
-
Scientific Director
Skills:
Leadership, Molecular Biology
Method And System For Biosynthesizing A Desired Biologically Useful Macromolecule In A Chlorella Cell And For Controlling Biosynthesis Thereof
US Patent:
6020156, Feb 1, 2000
Filed:
Mar 28, 1997
Appl. No.:
8/829613
Inventors:
Andrew Clive Cannons - Tampa FL
Hana Nenicka Dawson - Durham NC
Larry Paul Solomonson - Tampa FL
Hana Nenicka Dawson - Durham NC
Larry Paul Solomonson - Tampa FL
Assignee:
University of South Florida - Tampa FL
International Classification:
C12P 2102, C12N 113, C12N 1511, C12N 1579
US Classification:
435 691
Abstract:
Biosynthesis of a desired macromolecule includes inserting a promoter that encodes for an endogenously produced inducible macromolecule in a Chlorella cell into a DNA vector to form a first recombinant DNA vector. A cDNA sequence that encodes for the desired macromolecule is inserted into the first recombinant DNA vector to form a second recombinant DNA vector, which is then incorporated into the microalgae cell genome to form a transformed microalgae cell. Transcription and translation of the cDNA sequence are induced in the transformed microalgae cell to biosynthesize the desired macromolecule. Control of the method is achieved with the use of a mechanism effective in repressing an expression of the endogenously produced inducible macromolecule. Then, when desired, expression of the cDNA sequence may be induced by removing the repressing agent, thereby inducing a biosynthesis of the desired macromolecule.
Post Protein Hydrolysis Removal Of A Potent Ribonuclease Inhibitor And The Enzymatic Capture Of Dna
US Patent:
2013013, May 23, 2013
Filed:
Dec 21, 2012
Appl. No.:
13/725651
Inventors:
University of South Florida - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/24
US Classification:
435 30
Abstract:
The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.
Post Protein Hydrolysis Removal Of A Potent Ribonuclease Inhibitor And The Enzymatic Capture Of Dna
US Patent:
7416843, Aug 26, 2008
Filed:
Jan 14, 2005
Appl. No.:
11/035667
Inventors:
Matt Ewert - St. Pete Beach FL, US
Phil Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Phil Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68, C12Q 1/05
US Classification:
435 6, 435 14
Abstract:
The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.
Early Detection Of Pathogens In Blood
US Patent:
7998699, Aug 16, 2011
Filed:
Aug 15, 2003
Appl. No.:
10/604779
Inventors:
Matt Ewert - Seminole FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68, C12Q 1/54, C12Q 1/02
US Classification:
435 29, 435 615, 435 14
Abstract:
The present invention is a method of extracting infectious pathogens from a volume of blood including the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The fibrin lysis reagent is preferably composed of plasminogen and streptokinase frozen in coincident relation until the fibrin lysis reagent is needed whereby streptokinase enzymatically reacts with plasminogen to form plasmin upon thawing. The plasminogen is suspended in an aqueous salt solution prior to freezing including NaCl and NaPO.
Early Detection Of Pathogens In Blood
US Patent:
7993870, Aug 9, 2011
Filed:
Apr 1, 2009
Appl. No.:
12/416775
Inventors:
Matt Ewert - St. Petersburg FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68, C12Q 1/54, C12Q 1/02
US Classification:
435 29, 435 615, 435 14
Abstract:
The present invention is a method of extracting infectious pathogens from a volume of blood including the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The fibrin lysis reagent is preferably composed of plasminogen and streptokinase frozen in coincident relation until the fibrin lysis reagent is needed whereby streptokinase enzymatically reacts with plasminogen to form plasmin upon thawing. The plasminogen is suspended in an aqueous salt solution prior to freezing including NaCl and NaPO.
Early Detection Of Pathogens In Blood
US Patent:
2012003, Feb 9, 2012
Filed:
Aug 11, 2011
Appl. No.:
13/207894
Inventors:
MATT EWERT - St. Petersburg FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - TAMPA FL
International Classification:
C12Q 1/68, C12Q 1/44, C12Q 1/04, C12Q 1/02, C12Q 1/48
US Classification:
435 612, 435 29, 435 15, 435 34, 435 19
Abstract:
The present invention is a method of extracting infectious pathogens from a volume of blood including the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The fibrin lysis reagent is preferably composed of plasminogen and streptokinase frozen in coincident relation until the fibrin lysis reagent is needed whereby streptokinase enzymatically reacts with plasminogen to form plasmin upon thawing. The plasminogen is suspended in an aqueous salt solution prior to freezing including NaCl and NaPO.
Post Protein Hydrolysis Removal Of A Potent Ribonuclease Inhibitor And The Enzymatic Capture Of Dna
US Patent:
2012016, Jun 28, 2012
Filed:
May 8, 2008
Appl. No.:
12/117505
Inventors:
Matt Ewert - St. Petersburg Beach FL, US
Phil Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Phil Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C07H 1/08, C12S 99/00, C07H 21/04
US Classification:
435262, 536 2541
Abstract:
The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.
Post Protein Hydrolysis Removal Of A Potent Ribonuclease Inhibitor And The Enzymatic Capture Of Dna
US Patent:
2013011, May 9, 2013
Filed:
Dec 21, 2012
Appl. No.:
13/725924
Inventors:
University of South Florida - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68
US Classification:
4352891
Abstract:
The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.
Post Protein Hydrolysis Removal Of A Potent Ribonuclease Inhibitor And The Enzymatic Capture Of Dna
US Patent:
2013013, May 23, 2013
Filed:
Jan 4, 2013
Appl. No.:
13/734367
Inventors:
University of South Florida - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Philip Amuso - Tampa FL, US
Andrew Cannons - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68
US Classification:
435 5, 435 612
Abstract:
The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.